NSE filing, NSE: ICICIBANK. Summary written from the filing by ALFA Finder's alert engine.
ICICI Bank Ltd: key numbers
- Share price
- ₹1,398.00
- Market cap
- ₹10,03,901 Cr
- Revenue (annual)
- ₹1,95,218 Cr
- Net profit (annual)
- ₹54,208 Cr
- P/E (TTM)
- 17.0×Sector 19.8×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 34.68%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ICICI Bank Ltd
All →ICICI Bank Credit Rating
ICRA and CARE reaffirmed ICICI Bank's credit ratings on October 23, 2026, with ICRA withdrawing ratings on matured instruments. The filing discloses no new money raised.
ICICI Bank Employee Stock Options
ICICI Bank reissued 24,096 forfeited shares under its ESUS scheme on 22 Oct 2026. No issue price is disclosed in the filing.
ICICI Bank Other Announcement
ICICI Bank Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
ICICI Bank Management Change
ICICI Bank's Board approved seeking RBI approval for the continuation of Mr. Pradeep Kumar Sinha as Non-executive Part-time Chairperson until February 16, 2029.
ICICI Bank Earnings Call Transcript: Key Takeaways
Strong core operating profit growth of 21.8% YoY driven by robust loan expansion despite moderate NIM compression.
ICICI Bank Investor Presentation: Key Takeaways
ICICI Bank reported strong Q2-2027 performance with PAT up 20.1% YoY to ₹148.43 bn. Growth was driven by robust credit demand and stable asset quality.
Other regulatory approval announcements
All →Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.